Hepatitis C, Chronic

"Hepatitis C, Chronic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

INFLAMMATION of the LIVER in humans that is caused by HEPATITIS C VIRUS lasting six months or more. Chronic hepatitis C can lead to LIVER CIRRHOSIS.

Descriptor ID	D019698
MeSH Number(s)	C02.440.440.120 C02.782.350.350.120 C06.552.380.350.120 C06.552.380.705.440.120
Concept/Terms	Hepatitis C, Chronic Hepatitis C, Chronic Chronic Hepatitis C

Below are MeSH descriptors whose meaning is more general than "Hepatitis C, Chronic".

Diseases [C]
Virus Diseases [C02]
Hepatitis, Viral, Human [C02.440]
Hepatitis C [C02.440.440]
Hepatitis C, Chronic [C02.440.440.120]
RNA Virus Infections [C02.782]
Flaviviridae Infections [C02.782.350]
Hepatitis C [C02.782.350.350]
Hepatitis C, Chronic [C02.782.350.350.120]
Digestive System Diseases [C06]
Liver Diseases [C06.552]
Hepatitis [C06.552.380]
Hepatitis, Chronic [C06.552.380.350]
Hepatitis C, Chronic [C06.552.380.350.120]
Hepatitis, Viral, Human [C06.552.380.705]
Hepatitis C [C06.552.380.705.440]
Hepatitis C, Chronic [C06.552.380.705.440.120]

Below are MeSH descriptors whose meaning is related to "Hepatitis C, Chronic".

Below are MeSH descriptors whose meaning is more specific than "Hepatitis C, Chronic".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Hepatitis C, Chronic" by people in this website by year, and whether "Hepatitis C, Chronic" was a major or minor topic of these publications.

Bar chart showing 29 publications over 19 distinct years, with a maximum of 3 publications in 2019 and 2021

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1998	1	0	1
2002	2	0	2
2004	2	0	2
2006	2	0	2
2007	1	0	1
2008	1	0	1
2010	1	1	2
2011	1	0	1
2012	1	0	1
2013	1	0	1
2014	0	1	1
2015	1	0	1
2016	2	0	2
2017	1	0	1
2019	3	0	3
2020	1	0	1
2021	2	1	3
2022	1	0	1
2023	2	0	2

Below are the most recent publications written about "Hepatitis C, Chronic" by people in Profiles.

Gandhi MM, Nguyen KL, Lake JE, Liao D, Khodabakhshian A, Guerrero M, Shufelt CL, Bairey Merz CN, Jordan WC, Daar ES, Bhattacharya D, Chew KW. Proprotein convertase subtisilin/kexin 9 levels decline with hepatitis C virus therapy in people with HIV/hepatitis C virus and correlate with inflammation. AIDS. 2024 03 01; 38(3):317-327.

View in: PubMed
Jacobson JM, Zahrieh D, Strand CA, Cruz-Correa M, Pungpapong S, Roberts LR, Mandrekar SJ, Rodriguez LM, Boyer J, Marrero I, Kraynyak KA, Morrow MP, Sylvester AJ, Pawlicki JM, Gillespie E, Barranco E, Richmond E, Umar A, Weiner DB, Limburg PJ. Phase I Trial of a Therapeutic DNA Vaccine for Preventing Hepatocellular Carcinoma from Chronic Hepatitis C Virus (HCV) Infection. Cancer Prev Res (Phila). 2023 03 01; 16(3):163-173.

View in: PubMed
Jiang X, Diaby V, Vouri SM, Lo-Ciganic W, Parker RL, Wang W, Chang SH, Wilson DL, Henry L, Park H. Economic Impact of Universal Hepatitis C Virus Testing for Middle-Aged Adults Who Inject Drugs. Am J Prev Med. 2023 01; 64(1):96-104.

View in: PubMed
Jiang X, Vouri SM, Diaby V, Lo-Ciganic W, Parker R, Park H. Health care utilization and costs associated with direct-acting antivirals for patients with substance use disorders and chronic hepatitis C. J Manag Care Spec Pharm. 2021 Oct; 27(10):1388-1402.

View in: PubMed
Kim HN, Newcomb CW, Carbonari DM, Roy JA, Torgersen J, Althoff KN, Kitahata MM, Reddy KR, Lim JK, Silverberg MJ, Mayor AM, Horberg MA, Cachay ER, Kirk GD, Sun J, Hull M, Gill MJ, Sterling TR, Kostman JR, Peters MG, Moore RD, Klein MB, Lo Re V. Risk of HCC With Hepatitis B Viremia Among HIV/HBV-Coinfected Persons in North America. Hepatology. 2021 09; 74(3):1190-1202.

View in: PubMed
Sun J, Althoff KN, Jing Y, Horberg MA, Buchacz K, Gill MJ, Justice AC, Rabkin CS, Goedert JJ, Sigel K, Cachay E, Park L, Lim JK, Kim HN, Lo Re V, Moore R, Sterling T, Peters MG, Achenbach CJ, Silverberg M, Thorne JE, Mayor AM, Crane HM, Kitahata MM, Klein M, Kirk GD. Trends in Hepatocellular Carcinoma Incidence and Risk Among Persons With HIV in the US and Canada, 1996-2015. JAMA Netw Open. 2021 02 01; 4(2):e2037512.

View in: PubMed
Stevens ER, Nucifora KA, Hagan H, Jordan AE, Uyei J, Khan B, Dombrowski K, des Jarlais D, Braithwaite RS. Cost-effectiveness of Direct Antiviral Agents for Hepatitis C Virus Infection and a Combined Intervention of Syringe Access and Medication-assisted Therapy for Opioid Use Disorders in an Injection Drug Use Population. Clin Infect Dis. 2020 06 10; 70(12):2652-2662.

View in: PubMed
Sherif ZA, Nouraie M, Begum R, Afsari A, Shokrani B, Lee E, Laiyemo AO, Brim H, Ashktorab H. Factors influencing treatment outcome in hepatitis C virus minority patients at an inner-city hospital: A STROBE-complaint article. Medicine (Baltimore). 2020 Apr; 99(14):e19505.

View in: PubMed
Hall T, Jenkins CA, Hulgan T, Furukawa S, Turner M, Pratap S, Sterling TR, Tabatabai M, Berthaud V. Hepatitis C Coinfection and Mortality in People Living with HIV in Middle Tennessee. AIDS Res Hum Retroviruses. 2020 03; 36(3):193-199.

View in: PubMed
Sims OT, Chiu CY, Chandler R, Melton P, Wang K, Richey C, Odlum M. Alcohol Use and Ethnicity Independently Predict Antiretroviral Therapy Nonadherence Among Patients Living with HIV/HCV Coinfection. J Racial Ethn Health Disparities. 2020 02; 7(1):28-35.

View in: PubMed

People

Explore

Similar Concepts

Top Journals